Polish Investing Ideas

zł822.19
5.0% undervalued intrinsic discount
Set with the author's own calculation method
zł41.18
52.4% undervalued intrinsic discount
Fair Value
Profit Margin
15.31%
Future PE
24.26x
Price in 2030
zł64.25
zł330
118.4% overvalued intrinsic discount
Fair Value
Revenue
3.12% p.a.
Profit Margin
8%
Future PE
15x
Price in 2029
zł510.7
zł293.45
19.2% undervalued intrinsic discount
Fair Value
Revenue
9% p.a.
Profit Margin
50%
Future PE
13x
Price in 2030
zł472.61
SNT logo
Synektik Spólka Akcyjna

Cardiac marker could be a hit

In 5 years, the company should still be thriving, entering new markets and expanding in existing ones. Positive passage of the third stage of testing of a new cardiac marker could help.Read more

View narrative
zł204.19
93.0% overvalued intrinsic discount
Fair Value
Revenue
8.49% p.a.
Profit Margin
13%
Future PE
22x
Price in 2029
zł311.79
zł100.96
33.9% overvalued intrinsic discount
Fair Value
Revenue
15% p.a.
Profit Margin
46%
Future PE
12x
Price in 2028
zł133.69